Get a reply from this employer — a resume and cover letter tailored to exactly what they’re hiring for.
ARTO is seeking a Medical Director / Principal Investigator to lead Phase I clinical studies in its established Miami, Florida unit. You will oversee participant safety, study conduct and regulatory compliance on-site with a multidisciplinary team in a 144-bed clinical pharmacology facility.
The ideal candidate has MD/DO, board certification, 5+ years of clinical research, and PI/Sub-Investigator/MEDDIR experience, with strong GCP knowledge and sponsor collaboration skills.
Our partner, a leading global drug development organization supporting pharmaceutical and biotechnology companies, is seeking a Medical Director / Principal Investigator to join its established Phase I Clinical Research Unit in Miami, Florida.
This is an opportunity for a physician with clinical research experience to take a highly visible role within a dedicated 144-bed clinical pharmacology facility that has conducted almost 1,000 studies over the past 25 years and has access to a recruitment database of approximately 20,000 healthy volunteers.
The Medical Director / Principal Investigator will work hands-on across Phase I studies, taking responsibility for participant safety, medical oversight and study conduct while working closely with clinical operations teams and pharmaceutical and biotechnology sponsors.
Our partner is looking for a physician who can combine strong clinical judgement with an understanding of clinical research and participant safety.
Candidates should have:
This is a high-visibility physician position within a large, established Phase I research environment. The successful candidate will have the opportunity to take significant PI responsibility, work directly with leading pharmaceutical and biotechnology sponsors, mentor other clinical professionals and contribute to the continued development of the Miami research unit.
The position is on-site in Miami, Florida, and relocation can be considered for suitable candidates currently based elsewhere in the US.